Related references
Note: Only part of the references are listed.Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus Among Patients With Systemic Lupus Erythematosus: A Population-Based Study
Shahrzad Salmasi et al.
ARTHRITIS CARE & RESEARCH (2021)
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
Jianhua Wu et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Temporal relationships between systemic lupus erythematosus and comorbidities
Chang-Fu Kuo et al.
RHEUMATOLOGY (2019)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon et al.
RHEUMATOLOGY (2018)
Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort
Jayne Little et al.
RHEUMATOLOGY (2018)
Relationship Between Poverty and Mortality in Systemic Lupus Erythematosus
Edward Yelin et al.
ARTHRITIS CARE & RESEARCH (2018)
Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus
H. A. Chakkera et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
Sunghwan Suh et al.
ENDOCRINOLOGY AND METABOLISM (2017)
Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age
Marta Maria das Chagas Medeiros et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients
C. Munoz-Grajales et al.
LUPUS (2016)
Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study
Yi-Ming Chen et al.
RHEUMATOLOGY (2015)
Subsequent Type 2 Diabetes in Patients with Autoimmune Disease
Kari Hemminki et al.
SCIENTIFIC REPORTS (2015)
Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Laurence S. Magder et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Low Socioeconomic Status Is Associated with Cardiovascular Risk Factors and Outcomes in Systemic Lupus Erythematosus
Janet W. Maynard et al.
JOURNAL OF RHEUMATOLOGY (2012)
Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients
L. Yang et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus
Glinda S. Cooper et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Association of socio-economic status with diabetes prevalence and utilization of diabetes care services
Doreen M. Rabi et al.
BMC HEALTH SERVICES RESEARCH (2006)
Type 2 diabetes: principles of pathogenesis and therapy
M Stumvoll et al.
LANCET (2005)
Risk factors for coronary heart disease in women with systemic lupus erythematosus -: The Toronto Risk Factor Study
IN Bruce et al.
ARTHRITIS AND RHEUMATISM (2003)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
